Finance

Beta
Lists
AVXL:NASDAQ
Anavex Life Sciences Corp
$2.46
-3.91%
(-0.100) 1D
Jun 25, 3:08:29 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVXL...
Open
$2.58
High
$2.58
Low
$2.46
Mkt. cap
228.44M
Avg. vol.
1.40M
Volume
664.37K
52-wk high
$13.99
52-wk low
$2.41
EPS
-$0.46
Beta
1.20
Shares outstanding
92.67M
No. of employees
34
Open
$2.58
High
$2.58
Low
$2.46
Mkt. cap
228.44M
Avg. vol.
1.40M
Volume
664.37K
52-wk high
$13.99
52-wk low
$2.41
EPS
-$0.46
Beta
1.20
Shares outstanding
92.67M
No. of employees
34
News stories
From sources across the web
About Anavex Life Sciences Corp
CEOChristopher U. Missling Ph.D.
Employees34
Founded2004
HeadquartersNew York, New York, United States
SectorBiotechnology
Websiteanavex.com
Analyst ratings
Based on 2 analysts giving stock ratings to AVXL in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for AVXL in the last 3 months.
Highest
Current $2.46
$20.00 (+713.01%)
Average
$20.00 (+713.01%)
Lowest
$20.00 (+713.01%)
Analyst
Recommendation
Action
Price target
Projected
Date
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
$20.00
+713%
05/04/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$20.00
+713%
03/31/2026
Soumit Roy
JonesTrading
Hold
Maintained
-
-
11/14/2025
Awaiting results...
Call Time: Tue, Jun 16, 8:30 AM
Fiscal period
Q2 2026
EPS / Est. (USD)
- / -$0.07
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9.80M
9.83M
7.15M
4.62M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.62M
4.50M
3.68M
2.13M
Operating expense
12.42M
14.33M
10.83M
6.75M
Total operating expenses
12.42M
14.33M
10.83M
6.75M
Operating income
-12.42M
-14.33M
-10.83M
-6.75M
Other non operating income
-
25.00K
-
-
EBT including unusual items
-11.20M
-13.24M
-9.83M
-5.66M
EBT excluding unusual items
-11.20M
-13.24M
-9.83M
-5.66M
Income tax expense
-
-
-
18.00K
Effective tax rate
-
-
-
-0.32%
Other operating expenses
-
-
-
-
Net income
-11.20M
-13.24M
-9.83M
-5.68M
Net profit margin
-
-
-
-
Earnings per share
-0.13
-0.16
-0.11
-0.06
Interest and investment income
1.21M
1.08M
999.00K
1.08M
Interest expense
-
-
-
-
Net interest expenses
1.21M
1.08M
999.00K
1.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of AVXL
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer